Zivo Bioscience Inc (QB) (ZIVO) Quote

Lets go Zivo!!!!!

Oh, I totally agree with you on that...guess I should've stated such. I just meant exactly what you stated...**if** they are desperate, they will extend them at a lower price.

As I said way back in 2023, I am convinced they had a falling out with Armistice which caused the waterfall in late 2023 post-surprise increase split...and Armistice said "f u"...and just sold everything they could to recover as much as possible.

We'll soon find out the path ZIVO takes on this...

Just my opinion,

But I'd take the opposite opinion.

ZIVO and it's investors been burned by these financings. They've gone the way of the middle finger salute to IBs and hedgies for the last 18 months.
Not sure that I see that changing right now.

On top of it .... don't know how much they are engaged with Michigan and the Feds .... if they think they'll get awarded grants next month .... I'd preferably take those.... and LOL .... if there's a pharma deal involving money at or near completion ..... I'd let the warrants expire.

Of course repricing also shows weakness/desperation to an extent ..... and would likely drop the stock too.
But JMHO .....

Amigo Mike

And one item of note ..... at least dilution/money wise ..... the Series A 2 year warrant held by Armistice Capital for roughly 250,000 shares at $16.80 are no longer ... "in the money" at the current bid and they expire July 5, 2025. So we are within a couple weeks of some potential "funding" expiring off the books. This is $4.2 million were these to be exercised. I would think ZIVO receiving $4.2 million from these guys would be a material event needing to be reported but one never knows these days ...... dunno if ZIVO been in contact with them or not but just pointing out that a sizable warrant expiration is happening shortly.

In the absence of something tangible to move the stock price AND create enough volume to exercise these...they will likely re-price/re-structure them at lower price with an extended date imo. Would likely require them giving Armistice more warrants too though.

Yup.

I'm fairly certain 1 or more big animal pharmas were or are in play here given ZIVO's public statements. And I know pharma deals don't fall off trees and happen overnight. I get it .... but Payne tossed out a few bones and then has gone silent on what investors need to understand to make informed investment decisions.

At face value ZIVO still in the last window offered for a pharma deal ..... "1st half" ..... but that window is near closing.

I do wonder if Payne gone dark because the talks and deal are hot and wrapping up ? ..... or has it run cold ...... and ZIVO left at the alter again.

He could have very easily offered CEO letter as is fairly normal for the annual meeting. But didn't. WHY ?

And one item of note ..... at least dilution/money wise ..... the Series A 2 year warrant held by Armistice Capital for roughly 250,000 shares at $16.80 are no longer ... "in the money" at the current bid and they expire July 5, 2025. So we are within a couple weeks of some potential "funding" expiring off the books. This is $4.2 million were these to be exercised. I would think ZIVO receiving $4.2 million from these guys would be a material event needing to be reported but one never knows these days ...... dunno if ZIVO been in contact with them or not but just pointing out that a sizable warrant expiration is happening shortly.

Amigo Mike

Dahl 2.0. Still amazes me the board members that own almost half of the company have tolerated the incompetence. Although looking at their backgrounds it makes sense.

Anyway ...... investors still in the dark .... maybe Payne has something to say soon ... maybe not. A game of wait and see .... AGAIN.

Gwinner,

8K posted late this evening.

Of course it sez absolutely nothing about anything of value. No CEO address to shareholders. Solely the voting results of the annual proxy.
https://www.sec.gov/ix?doc=/Archives/edgar/data/1101026/000165495425006837/zivo_8k.htm

Annual shareholders meeting and you post zippo .... no recap of where you've been ... no where expecting the company to go from here .... nada.
WTG ZIVO ...... just another miss to add to the pile.

And this is the info from the USDA website that leads me to believe we would hear something on the federal grant roughly July.
Announcements on the APHIS website "mid 2025" and project should start no sooner than August 1, 2025 which means the awards would be funded end of July or early August presumably.
https://www.aphis.usda.gov/funding/hpai-poultry-innovation-grand-challenge/faq

>>>>>>
When and how will I find out if my proposal is funded, and when will funds be awarded?
APHIS will publish the spending plan and list of projects resulting from this funding opportunity and notify applicants of their award status promptly after the spending plan is approved by USDA. Applicants will be notified by email and through announcement of the awarded projects on the APHIS website. We anticipate announcing awarded projects in mid-2025.
>
When should the project start and end? How long will I have to complete the project?
We recommend that cooperators plan for project start dates no sooner than August 1, 2025, but we may allow flexibility to accommodate specific project needs. A project’s duration will depend on the nature and scope of the project, but we expect all projects to be completed no later than 3 years after the start date.

Gwinner,

Some selling is not really a surprise to me at this point ....

Mgmt has basically been a complete failure in the communications dept and has not delivered a coccidiosis license. As I already noted ..... Payne has left investors with nothing to hang their hat on for any time line to execute just about anything.

Coccidiosis license ? Last public statement was they expected deal in the first qtr. Only if you are following along very very closely would you know that was walked back for reasons unknown and restated as 1st half.

Avian Flu ..... next test when ? State and federal grants applied for free money. No timeline. The federal grant is closed to submissions. I believe the applications are reviewed now and I think the awards would be announced in July if I understand what I read on the grants. This one is intriguing to me cause I don't know that I've yet to see anyone with some sort of solution option to the avian flu situation. We'll see I guess. But no timeline on more tests either. Next steps, etc.

I also have a problem with the ZIVOlife vertical. Obvious there is some massive disconnect there. Not doing jack. Past time for a move there one way or another.

No 8K filed still with regard to annual meeting/proxy results. Another opportunity to communicate ..... still not filed.

So .... frankly ... I'm not surprised to see selling. Honestly a CEO's job isn't to care much about day to day stock price movement like an investor would. CEO's job is to build company value. Thus far Payne has moved the company to the cusp of monetizing a product candidate and I believe built value. But we are at the point that investors are generally flying blind based on company provided information. And it is also why I'm much more inclined these days to advocate that Payne sell the company to someone who can explore and monetize the vertical possibilities. It is time for action !

Amigo Mike

Still no 8-K for annual meeting outcome. What are they hiding?

And still selling. Of course no support of the stock from Zivo.

Welp OTCN got there shares sold....

Where is grandpa’s boot licker?

Lack of news on annual meeting leads me to believe investors who do not get private placement deals and free shares about to get hosed again.

OTCN wanting to unload some ZIVO shares today...but no takers so far

Apparently no one rushed out of the annual meeting to buy stock.

Still clinging to that $50 a share huh?

Thanks Mike for the awesome lesson. I needed that. Still curious why the RS did not affect the Warrant total.

Gunner,

I hope this helps a little.

https://www.empower.com/the-currency/money/stock-warrants

The ZIVO warrants currently expire at the end of April 2026 and have a strike price of $33.

I am of course on record as indicating .... my opinion .... ZIVO is a $50 stock with a coccidiosis license. I've had that opinion for quite some time. As it relates to the warrants ..... anything higher than $33 puts them in the money and exercisable if an investor chooses to do so by calling the company and requesting exercise which involves you send them your warrant and $33. So if the stock rises to $50 as example ...... your cost is the $33 plus the cost of your warrant in exchange for a newly issued share from the company. So if you paid 50 cents for the warrant as example ... your cost would be $33.50 for a newly issued share that is presently worth $50. You have instant gain of $16.50. Your other choice would be to sell warrant on the open market where the price should reflect the value of the warrant strike ($33) difference to the current market price plus time and greeks at the time. So one might assume the warrant to trade on the open market around $16.50 if the stock was $50.

But it is unclear what ZIVO is actually doing at this point. Coccidiosis testing based on public statements .... I believe ZIVO and at least 2 major animal pharmas have done validation tests on ZIVO's product candidate. I have been investing the the baby biotech space for roughly 40 years so I know deals with the big boys take forever ...... but it's really unclear at this point why a coccidiosis license hasn't been struck as yet.

Add avian flu ..... new product vertical. It makes sense that ZIVO would begin to add new vertical options with coccidiosis more or less proven to the "nth" degree. But avian flu seems like it may have altered the path for a coccidiosis license.

And now we have 2 submissions for state and federal grants (which I might add that I suggested to Dahl YEARS ago) that we don't have a timeline for. I do believe I read that at least the federal grant should have the review board award decisions mid summer. So roughly July. The Michigan state grant ... don't know what grant was applied for so can't look it up.

So investors are left hanging .... again ..... for a coccidiosis timeline and even what's next other than more avian flu testing. Payne's communication is not much better than Dahl's and in some ways .... worse ... because at least Payne has ZIVO at the point of monetization.

Make no mistake the above addition of Avian flu and submissions for free money are things that should add to the value of this company .... but the market doesn't know what's next and Payne has given the market nothing to work with on whether investors should be considering buying the stock or not.

The shareholder meeting is Monday June 9th 10AM at ZIVO's new HQ .... in person only. I didn't bother to arrange to go ... but I probably should have. Had expected to see a deal of come sort with major pharma by now. With no call in or anything ..... looks like investors will be waiting to see what tidbits are offered in the 8k filing with the shareholder address. IMO 2024 was a successful year, but ultimately those successes need to be monetized sooner rather than later.

Amigo Mike

Thanks Mike. I have warrants, however; I’m not sure I totally understand them.

Gunner,

I think the warrants been getting dumped on and no real buyers to take them. There is also the element of time decay .... coupled with the lack of volatility ..... as these are somewhat priced like options. So time fades daily ..... and no movement in the stock ..... the greeks decline .... so less value .... until such time as the landscape changes. These warrants are at $33 ..... so the stock price is more or less half of that presently with about 1 year to go. Of course the right kind of news could change everything this afternoon .... but who knows when ZIVO will next provide info ?

ZIVO silence and lack of progression biting shareholders in the ass ........ again. Communication hasn't gotten any better under Payne. The progress is more tangible toward regulatory process and licenses but .... here we are ...... thumb up our ass and no timeline for anything.

As the days go by ....... I'm more and more aligned to the idea that mgmt should be selling the company.
It's ridiculous for shareholders to be left in the dark over and over again.

Obviously we know ZIVO and major animal pharmas have tested coccidiosis to death and its proven effective on multiple levels. We have no timetable for anything more.

Obviously we know about the new avian flu tests. Given the newness .... it's got a ways to go ... however we now have no timeline for anything here either.

We know about grant requests to the State of Michigan and the federal gov't. All we know there is deadline for the federal grant was 2 weeks ago ... and ?

The ZifoLife stuff ..... I don't understand that ..... if the distributor isn't making it happen .... GET RID OF THEM. If Zivo is the problem, THEN FIX IT. Or ... sellit to someone that can do something with it.

Amigo Mike

Typical zivo. Poor study results and no interest in licensing so they go silent.

What happened to ZIVOW ?

Hopefully grandpa wakes up in time for the annual meeting.

More Pharma deals getting done today.....Lets go ZIVO and make a deal!!!!!

Look at that volume. Turd must be working overtime communicating with investors and building interest in the stock.

I am sure the “first offer” was years ago and grandpa failed to act on it.

ZIVO - Its time to make a deal here! Strike while deals are getting done! The first offer might be your best offer too!

Looks like Dahl’s latest company is a bust.

https://trellis.law/case/26125/2025-211967-cz/american-express-national-bank-vs-fowler-casey

This BOD sure knows how to find talent!

Gwinner,

LOIs are worthless. But I get what you are saying if pharma can be named. LOIs aren't binding deals. They are just stated intent to do something which may or may not ever happen. ZIVO doesn't need any more in the "may or may never" happen category. They need definitive deals .... and it's well past due.

I'm on record as saying this should be a $50 stock with a coccidiosis deal with a major animal pharma.
Grants .... not sure what they will do for the stock price ...... Obviously money in the bank and a big win for the company and investors ....... but that money is for continued research in new vertical. Monster bonus for investors that it reduces the potential for dilution. But time and research are what that is for. And of course "how much" is received in grants would be a factor. I'd be thrilled for $5.5 million from Michigan. Can't say I know what to expect from the USDA grant offering but I'd guess if ZIVO asked for $5.5 million from Michigan .... they be asking for more than that from the USDA.

The research, testing and governance is all in place for coccidiosis. SHOW ME THE MONEY ! Bird Flu is new and interesting but it isn't something that can produce revenue to ZIVO now. And the ZivoLife stuff ..... geezus they need to kick Z WorldWide to the curb ... have a plan .... either kick it in gear or sell that business to someone that will do something with it. Wasting time there too.

Wouldn't shock me if ZIVO wanted to get back on NASDAQ .... but silly chit like the current situation i.e. what's next and when .... is a monster problem for NASDAQ. Analysts will laugh at that and shorts will drive it into the ground again if there isn't regular news and progress toward revenue/profit generating activities. For instance, can you tell me what the prospective annual revenue might be if ZIVO for instance signed a deal today to bring a therapeutic to market for coccidiosis ? You can't .... pretty sure ZIVO can't ... and can't say "when" anything. How would a Wall Street analyst even have the info to put out a research report much less a buy recommendation ?? And you saw what happened with first time on NASDAQ. The Maxim "analyst" still puts out updates on ZIVO every once in a while. The Maxim reports are quite frankly the worst analyst research reports I've ever seen ... and that is 100% on ZIVO. IMO this company belongs on the auction block. Not NASDAQ. Once there is a bite at the apple by a major animal pharma, that's all the validation needed. The verticals are plenty .... in human and animal health. A company with the resources can take it and run .... ZIVO .... =) ..... you've seen the last decade plus right ? With the potential verticals .... right now I don't think ZIVO could get a billion dollars for the company but I'd take anything above $500 million at this point in time.

Amigo Mike

The only options that make sense are grandpa is totally senile and incompetent or purposely keeping share price down. I am beginning to think it is the former. It appears his pet marijuana business is a bust.

The job of a CEO is to promote the company and support the share price, and at a minimum communicate with investors. He fails across the board.

Amigo, I know this goes without saying but, if Zivo could just get a letter of Intent from a Pharma company or some type of Letter of Interest indicating a framework of a deal or a structure that shows an income stream this would take out all Sellers from $18 to $40+ per share in my opinion...Also, if any announcement securing funding from a grant or federal funded program would also catapult this thing to a much higher level.

I do agree that if they can swing it they should move back to NASDAQ but only if the proper funding or deal is in place...

I can't help to think that with the last two avian flu tests it had to peak some interest with other pharma companies looking to leap frog into this field.

But if a big pharma company just wants the whole company with its intellectual properties etc., then YES your $200 price point could be achieved imo.

Lets go Payne...make a deal...

Today,

Some sellers look like they are back at the window at $18 .... and of course someone else is itchy to be first in line .... at $17.99.

The current issue here is it is anyone's guess as to what and when the next news is. Not the best situation for a company like this to be in and certainly not the best for investors ..... or attracting investors to the company. Well Done ZIVO !!

Since it was already noted in PR, I doubt there would be more info on the USDA grant filing but will be interesting to see if ZIVO can land some money here.
https://www.aphis.usda.gov/funding/hpai-poultry-innovation-grand-challenge

The FAQs are very interesting. If you haven't already done so ..... the "funding priorities" and "therapuetic priorities" section is intriguing.
https://www.aphis.usda.gov/funding/hpai-poultry-innovation-grand-challenge/faq
ZIVO could potentially stand out for novel non vaccine therapeutics to eliminate or control disease. And the site indicates >>>>>We anticipate announcing awarded projects in mid-2025.

Gwinner,

Anything can happen of course.
Currently L2 is back to about as thin as it gets .... so no indication of any buying .... or selling ... interest .... at this moment in time.

As I noted .... ZIVO has left investors now with no timeline for anything outside of grant filing deadline for USDA on May 19. Public comments that expected deal for coccidiosis license in the 1st qtr ... has come and gone with no comment at all from ZIVO. Unless you are following closely you wouldn't know ZIVO backed off that timeline .... but another fail in my book on the communication front. So a bit surprising to see buyer take size yesterday ... relatively speaking.

So it's a guess as to when next news comes. NOT IDEAL .... par for the course for ZIVO. Investors always left with wondering .... WHEN. I am guessing that mgmt has learned the lesson the past 2-3 years that stock price matters .... and it is something that should be paid attention too. But apparently haven't learned anything on the communication front. NO explanation on status.

So much else occurring in the marketplace and ZIVO back to mostly silence and slow drawn out nothingness with the occasional positive test result. A don't see much action happening in ZIVO until there is more visibility into what's going on with licensing and deals with animal pharmas.

So I'm in wait mode here.
Amigo Mike

Yeah, I saw that eod trade come across yesterday...kinda interesting that the Buyer was the first trade of the day at 9;30 and last trade of the day...Hopefully we get some follow through buying again today.

As for the follow-through news I'm hoping for...I just figure that with each press release indicating they have identified more applications and better efficacy with there products that there has got to be pharma company watching from the sidelines and bound to make ZIVO an offer of sorts...

Welp.

5,000 shares bought on the offer for today. More action than there's been in a while. But given the available shares .... didn't really go anywhere on that volume. Hopefully at least a seller may have been cleaned out. But that remains to be seen.

Amigo Mike

Gwinner,

There was a seller sitting above the market on $18 and just under 3,000 shares available for several days.
Kinda looks like someone decided to go up and clean that out.

Same offer hasn't appeared on L2 today so assume that seller was taken out.

Kinda sucks we are left with zero timelines for anything outside of the USDA grant submission deadline next week for Avian Flu.
Frankly ZIVO should have someone full time scouring govt' grants on just about anything under the sun that is rooted in inflammation and submitting requests for any money they can get their hands on.

PR sez Michigan grant request was made sometime previous to the PR. A week, a month, a year ... who knows .... and who knows when/if grant would be awarded.
No info on next round for avian flu.
No info on coccidiosis status.

Ho hum ....... classic ZIVO. Same chit, different year. I still think it is a $50 stock with a coccidiosis license with a big boy and much more with avian flu in the mix ..... but we are back to ..... not knowing what's next ... and when ...... at this point. And this is an ongoing problem here.

Amigo Mike

Nice to see a little buying at the open today!
Hopefully we get some follow through news soon!

Unfortunately,

I dont think we will see liquidity anytime soon.

There's really very little float to work with presently and we are OTC. Gotta be around 2 million shares free trading and I'm pretty sure in that 2 million shares there are a fair number of those tightly held by investors that have been around for a while and are waiting for payday. So I believe float is smaller than that.

Kinda funny. Were ZIVO to land $5.5 million from Michigan and more from USDA .... I'll just call it another $5 million .... if those are received around the same time, they should qualify to relist on NASDAQ. Still think it would not be liquid but if there's news and deals anything can happen .... and eventually they could do forward split to expand the share count. On Nasdaq would certainly get more attention.

We'll see.
Amigo Mike

I'm for anything that returns liquidity to this thing and gets rid of the $2, $3, up to $4 at a time spread between bid/ask that makes it IMPOSSIBLE to trade or even own any amount of size without massive risk.

Most days, attempting to buy even a measly 1k shares on the offer you have to accept a $3-$5k instant loss as a possibility (and that's assuming the bids even stack up enough to support that measly 1k shares lol).

Since we're making everything great again...can we please make ZIVO liquidity and trading great again too?? 🤣🤣🤣🤣

JP is definitely ultra conservative when it comes to releasing info…I think you are also 1000% correct about the bird flu studies changing the narrative for ZIVO… I found it interesting, that’s the last two PR’s, since the one released on 12/23/24 that mentioned a possible coccidiosis Q1 license, were about bird flu progress, never mentioning coccidiosis… could it be that the coccidiosis testing is actually complete???…, and if in fact, coccidiosis testing is complete, and the bird flu studies continue to progress, hmmmm….

Algaeboy,

Yes everyone is looking for "MONEY" related news.
The grant money ...... I think Payne is ultra conservative in what he sez publicly.
Like I said ... don't know Michigan timeline ... and USDA deadline is May 19.
Payne gave a specific amount for Michigan and said it's been requested/submitted. So my assumption there is that grant could happen any time.

It ..... {{{feels}}} to me like the introduction of the bird flu vertical has shifted the conversation Payne may be having with these global pharmas. And also may be reason for a delay in getting to a monetary deal.

The bottomline is that every vertical raises the value of this company. Coccidiosis testing as far as I know is done and no additional tests are needed. Avian Flu just getting started. But I'm not sure ..... if I'm a global animal pharma ... or even if I'm ZIVO .... if I want my hands on ALL of it ... or just pieces of it.

As far as I know ..... and I'm certainly not an avian flu expert ..... NO ONE has a solution to avian flu. You see the news ... destroying the birds is the main current solution. If NO ONE has a solution to avian flu ..... but along comes a biotech with a NON ANTIBIOTIC option (bonus) that still needs some validation but shows promise ...... one can only guess the value that might bring to ZIVO or a potential acquirer/partner. And as far as grants ...... if ZIVO shows potential solution ..... I would think is certainly a grant candidate.

In addition, in some of the past tests for bovine mastitis and coccidiosis, there were OTHER impacts observed against other infections/disease that were NOT the target of the tests. So if global animal pharmas are circling and reviewing all of ZIVO's data, there has got to be some "ah ha" type moments happening with new eyes looking at it and potentially more vertical applications. Unfortunately global animal pharmas don't move fast but they are hurting for new product candidates especially in the food supply arena. So its a guessing game on what finally compels the big boys to move outside of the almighty dollar.

My opinion remains as it has always been. This is a potential "B"illion dollar company/value .... with a "B" ...... whether it is realized ....... ever ... remains to be seen. I would think a buyout is more appropriate as global animal pharma can then go off and test all kinds of targets in short order. And we aren't even talking about the .... human .... possibilities here.

I'm curious...... if ZIVO announced that grant from the STate of Michigan tomorrrow ... are you a buyer of the stock ? =)

Amigo Mike

As usual,

You don't get it. I'm not catching on to anything. I understand how things go in this realm . Quite obvious ..... you don't.

Still waiting to see your insider buys at "cheap" prices. Hasn't happened.

I still didn't see a reply from you when I asked what the cost is that insiders get to buy at. Well ????

Its obvious you don't know cause your assertions are totally wrong at the point they are made. The reason I know that ... is because I know the formula being used for insiders to buy .... I know .. because I asked how that is being determined and I'm fairly certain it is actually disclosed in the filings. And they are only buying if/when they have to. Wall Street IBs are scumbags and rape and pillage companies seeking to do raises. I'll take the insider funding all day ... every day .... cause the pricing is understood without extra pillage ..... and the shares won't be used to further destroy the company. But people like yourself just let their mouth runneth over .......

Making disparaging remarks about CEO's age (i.e. granda) as well as making fun of IR's name ..... speaks volumes about you.

I'm very surprised that ZIVO mentioned the grant applications to Michigan and the USDA ... if that happens ... insiders don't need to buy now do they ???

The USDA grant application deadline is in less than 2 weeks. Not sure what the timeline for Michigan is. Payne must be very confident in landing some of that cash to put out that grant info.

Amigo Mike

Welcome Hudson,

I see you have a shiny new handle there.
20 years wow .... you are an old timer like some of us on the board. I surely hope that you've taken advantage of the ups and downs here to mitigate your risk.

Given you've been around so long ... begs the question as to whether I know who you are .... LOL .... Given the shareholder base that's owned this for that long is tiny.

Curious what you are hearing for end of month. LOL.

Amigo Mike

Mike,

IF, and its a big if, Z is able to secure any of grants, particularly from the USDA, that would be the type of real news that we’ve been waiting YEARS for… Get funding for bird flu research, secure a coccidiosis license, even a small one, then things might FINALLY start to get interesting 🤞🤞

Hudson, what news are you hearing is happening at the end of the month?

Heard what should be great news at the end of the month. Have been vested 20 plus years. Like to think close to popping. We shall see

Now you’re starting to catch on. Tird posted the release for compliance purposes, not to draw attention to the stock. They had material information and needed to share it. Obviously they do not want to see the share price higher since insiders plan on getting more cheap shares.

Gwinner,

Yeah .... nice news .... but not what folks are looking for at this point in time.

The silence doesn't cut it.
PR released at 6PM ... doesn't cut it. Person in charge of PRs should be fired. This isn't the first time. But it damn sure should be the last. Might as well release at midnight when everyone is inspecting the insides of their eyelids.

LICENSE / JV with animal pharma i.e. MONEY $$$$$ CHA CHING ... whatever you wanna call it ... is what investors are looking for.
If that isn't happening .... need to SELL THE COMPANY to someone who can get the job done. It's literally been 20 years here. More than 10 years since they actually got serious about the research behind the algae.

Avian flu is a new vertical just added late last year .... so all the testing protocols and validations are necessary ... separately ... for each vertical. It is what it is and has to happen with every new target. So Avian flu test results show that a particular formulation shows results ... albeit not statistically significant at this point. And the U of D PhD said ..... any positive result is a big deal in this vertical.

What I find most interesting from the release is what you pointed out. Submissions for state and federal GRANT MONEY.
Michigan - $5.5 million
USDA - a piece of $100 million in free money for Avian Flu research

Funny with less than 4 million shares out ..... Michigan grant of that size would mean more than $1 / share and pretty much fund a fair portion of a year's worth of testing. USDA ... anyone's guess on how much ZIVO would be asking for there but obviously a big pot of money. And with USDA looking for non antibiotic options ..... good move to see what they can get. Wouldn't shock me if ZIVO got money from Michigan but I wouldn't expect they get the full $5.5 million. USDA I'd be happy with $4-5 million outta that pot of money. One thing that gives me pause about these grants is they are geared towards HPAI and ZIVO first tests here are LPAI targeted. Dunno how much crossover or significant from a research perspective that is cause I'm not a Phd but something to keep in mind.

Amigo Mike

Well, we have now heard from the company...Finally.....I like the fact they are applying for some grant money. Obviously, they are in the right spot for these type of applications and they probably need the money to keep things rolling...

With the various milestones achieved, its gotta peak the interest of some of these pharma companies...maybe we get a follow through PR????